| Financial Year |
March 31 2023 |
| Monetary Funds |
173,737,195.44 |
| Held-for-trading Financial Assets |
318,690,599.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
170,615,935.75 |
| Advances to Suppliers |
1,331,363.39 |
| Other Receivables |
430,424.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,196,439.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
209,363.68 |
| Total Current Assets |
771,712,290.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
123,186,119.86 |
| Under-construction Projects |
127,191,661.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,155,542.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,163,747.73 |
| Other Non-Current Assets |
2,058,066.80 |
| Sub-Total of Non-Current Assets |
283,958,472.74 |
| Total Assets |
1,055,670,763.45 |
| Short-Term Loans |
46,010,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,440,000.00 |
| Accounts Payable |
70,670,788.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,707,407.47 |
| Taxes Payable |
5,041,502.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,349,340.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,225.82 |
| Other Current Liabilities |
300,300.79 |
| Sub-Total of Current Liabilities |
153,867,571.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
514,288.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,515,130.73 |
| Total Liabilities |
158,382,702.26 |
| Paid-In Capital(Or Share Stock) |
106,666,700.00 |
| Capital Surplus |
531,524,002.71 |
| Surplus Reserve |
27,534,969.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
231,562,389.17 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
897,288,061.19 |
| Owner's Equity（Stockholder's Equity） |
897,288,061.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,055,670,763.45 |
